...
机译:Ticagrelor与氯吡格雷患者患有症状外周血动脉疾病和先前冠状动脉疾病:欧遗址试验的见解
NYU Sch Med Dept Med 530 First Ave Skirball 9R New York NY 10016 USA;
Univ Toronto Toronto ON Canada;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Univ Bern Bern Univ Hosp Inselspital Swiss Cardiovasc Ctr Bern Switzerland;
Univ Edinburgh Usher Inst Populat Hlth Sci &
Informat Edinburgh Midlothian Scotland;
AstraZeneca Gothenburg Molndal Sweden;
AstraZeneca Gaithersburg Gaithersburg MD USA;
Orebro Univ Fac Med &
Hlth Orebro Sweden;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
AstraZeneca Gothenburg Molndal Sweden;
AstraZeneca Gothenburg Molndal Sweden;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Univ Colorado Sch Med Aurora CO USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Stanford Univ Sch Med Stanford Ctr Clin Res Stanford CA 94305 USA;
acute limb ischemia; cardiovascular events; coronary artery disease; major bleeding; peripheral artery disease (PAD); ticagrelor; antiplatelet therapy;
机译:Ticagrelor与氯吡格雷患者患有症状外周血动脉疾病和先前冠状动脉疾病:欧遗址试验的见解
机译:TiCagreloLoLOR和Clopogro患者对外周血(EUCLID)试验患者的影响设计和理由
机译:TicagreloLoR与氯吡格雷与外周血疾病患者相比的影响(EUCLID)
机译:有症状冠状动脉疾病患者的多探测器CT表现与血管造影报告的狭窄之间的相关性:先导研究
机译:慢性自我感知患者与外周血动脉疾病患者死亡率和健康状况结果的关联:肖像登记处的见解
机译:患有心血管和肢体结果的健康状况分数与症状外周血疾病患者的结论:来自EUCLID的见解(检查症状外周动脉疾病中TiCagrelor的使用)试验
机译:TiCagrelor对患者对症状外周血疾病和先前冠状动脉疾病的患者:来自欧几里德试验的见解